These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2454597)

  • 1. [Metabolism and pharmacokinetics of natural immunomodulators].
    Bocci V; Pacini A; Pessina GP; Maioli E
    Ann Ist Super Sanita; 1987; 23(4):761-3. PubMed ID: 2454597
    [No Abstract]   [Full Text] [Related]  

  • 2. Interleukins. Clinical pharmacokinetics and practical implications.
    Bocci V
    Clin Pharmacokinet; 1991 Oct; 21(4):274-84. PubMed ID: 1760900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes of the CD69 expression and cytokine secretion in confined environment].
    Shimamiya T; Wakabayashi S; Terada N; Horiuchi J; Naraki N; Mouri M
    Biol Sci Space; 2002 Nov; 16(3):138-9. PubMed ID: 12695590
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetics of tumor necrosis factor alpha after intravenous administration in rats. Dose dependence and influence of tumor necrosis factor beta.
    Zahn G; Greischel A
    Arzneimittelforschung; 1989 Sep; 39(9):1180-2. PubMed ID: 2590273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of recombinant human tumor necrosis factor-alpha in rats. Effects of size and number of doses and nephrectomy.
    Ferraiolo BL; McCabe J; Hollenbach S; Hultgren B; Pitti R; Wilking H
    Drug Metab Dispos; 1989; 17(4):369-72. PubMed ID: 2571474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Favorable response of advanced hepatocellular carcinoma to proper hepatic arterial administration of cytokines and the significance of the administration].
    Fuchimoto S; Yasui Y; Gouchi A; Hamada F; Sanada E; Urakubo M; Okura M; Akamatsu Y; Sasaki A; Orita K
    Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2396-400. PubMed ID: 2458070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Radioprotective effect of a complex preparation of lymphokinin cytokines].
    Boĭko VN; Shadrin OV; Derevianchenko IG; Buntsevich AM; Bykovskaia SN
    Biull Eksp Biol Med; 1994 Jul; 118(7):38-40. PubMed ID: 7919271
    [No Abstract]   [Full Text] [Related]  

  • 8. Central nervous system toxicity of interferons and other cytokines.
    Bocci V
    J Biol Regul Homeost Agents; 1988; 2(3):107-18. PubMed ID: 2474235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering interferons and interleukins for cancer immunotherapy.
    Holder PG; Lim SA; Huang CS; Sharma P; Dagdas YS; Bulutoglu B; Sockolosky JT
    Adv Drug Deliv Rev; 2022 Mar; 182():114112. PubMed ID: 35085624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interleukins and TNF in septic shock].
    Guidet B; Staikowsky F; Offenstadt G
    Rev Prat; 1993 Jan; 43(1):13-7. PubMed ID: 8469892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug interaction studies of therapeutic proteins or monoclonal antibodies.
    Mahmood I; Green MD
    J Clin Pharmacol; 2007 Dec; 47(12):1540-54. PubMed ID: 17962422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and tissue distribution of recombinant human tumor necrosis factor-alpha in mice.
    Ferraiolo BL; Moore JA; Crase D; Gribling P; Wilking H; Baughman RA
    Drug Metab Dispos; 1988; 16(2):270-5. PubMed ID: 2898346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocrine effects of cytokines.
    Vassilopoulou-Sellin R
    Oncology (Williston Park); 1994 Oct; 8(10):43-6, 49; discussion 49-50. PubMed ID: 7528526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interleukins in stomach and duodenal ulcers].
    Sokolova GN; Tsaregorodtseva TM; Zotina MM; Dubtsova EA
    Eksp Klin Gastroenterol; 2002; (1):40-2, 191. PubMed ID: 12271582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine profiles of canine monocyte-derived dendritic cells as a function of lipopolysaccharide- or tumor necrosis factor-alpha-induced maturation.
    Wang YS; Chi KH; Chu RM
    Vet Immunol Immunopathol; 2007 Aug; 118(3-4):186-98. PubMed ID: 17617471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of protein anticancer agents.
    Bocci V
    Pharmacol Ther; 1987; 34(1):1-49. PubMed ID: 2443936
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of tumor necrosis factors, interferons, interleukins, and growth factors on the activation of NF-kappa B: evidence for lack of correlation with cell proliferation.
    Chaturvedi MM; Higuchi M; Aggarwal BB
    Lymphokine Cytokine Res; 1994 Oct; 13(5):309-13. PubMed ID: 7532017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individual differentiation of innate antiviral immunity in humans; the role of endogenous interferons and tumor necrosis factor in the immunity of leukocytes.
    Orzechowska B; Antoszków Z; Błach-Olszewska Z
    Arch Immunol Ther Exp (Warsz); 2003; 51(1):51-60. PubMed ID: 12691304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue distribution, stability, and pharmacokinetics of Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand in human colon carcinoma COLO205 tumor-bearing nude mice.
    Xiang H; Nguyen CB; Kelley SK; Dybdal N; Escandón E
    Drug Metab Dispos; 2004 Nov; 32(11):1230-8. PubMed ID: 15282212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The introduction of interleukins to the world].
    Pelet B; Gautier E
    Rev Med Suisse Romande; 1991 Oct; 111(10):879-83. PubMed ID: 1719599
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.